Dracen Pharmaceuticals, Inc.

Dracen Pharmaceuticals, Inc.

Dracen Pharmaceuticals, Inc.

Overview
Date Founded

2016

Headquarters

1812 Ashland Avenue,Ashland Building,1st floor, Suite 100,Baltimore, MD 21205

Type of Company

Private

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Holding Companies

Company Description

Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in Baltimore, MD.

Executives & Employees

Co-Scientific Founder

Co-Scientific Founder

Co-Scientific Founder

Co-Scientific Founder

President, Chief Executive Officer & Director

Vice President, Finance

Board of Directors

Chief Science Officer at Deerfield Management Company LP

Founder at Jounce Therapeutics, Inc.

Partner, Private Transactions at Deerfield Management Company LP

President, Chief Executive Officer & Director at Dracen Pharmaceuticals, Inc.

Paths to Dracen Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Dracen Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Dracen Pharmaceuticals, Inc. raised money in a private placement transaction

Advisors & Consultants
Advisor

Founder at Sitryx Therapeutics Ltd.

Advisor

Co-Scientific Founder at Dracen Pharmaceuticals, Inc.

Advisor

Co-Scientific Founder at Dracen Pharmaceuticals, Inc.

Investors
Details Hidden

Deerfield Management Co. LP (Private Equity) invests in a broad range of industries. It provides financing for buyout transactions to private and public companies located in the U.S.

Details Hidden

Osage Ventures invest in companies founded by scientists, academics, and students. The firm targets companies operating in the fields of software, hardware, therapeutics, medical devices, diagnostics. It provides financing forall stages capital requirements.Osage Ventures invests in determined and creative entrepreneurs that have a unique concept or product. The firm provides capital and value-added services to early-stage, middle-market information technology/enabling technology, manufacturing, industrial and life science/healthcare businesses in the Northeast corridor. Initial investments range from $1 million to $3 million.

Details Hidden

Co-Scientific Founder at Dracen Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dracen Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dracen Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Dracen Pharmaceuticals, Inc..